US Stock MarketDetailed Quotes

Apellis Pharmaceuticals (APLS)

Watchlist
  • 40.790
  • +0.140+0.34%
Close Apr 10 15:59 ET
  • 40.710
  • -0.080-0.20%
Post 20:01 ET
5.21BMarket Cap226.61P/E (TTM)

Apellis Pharmaceuticals (APLS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
151.59%45.33M
-173.22%-14.18M
218.13%108.47M
153.30%4.45M
59.84%-53.41M
85.23%-87.87M
119.78%19.36M
120.17%34.1M
94.45%-8.34M
25.13%-132.98M
Net income from continuing operations
111.31%22.39M
-62.16%-58.95M
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
Operating gains losses
----
----
----
----
----
1,524.17%1.95M
--0
--0
----
----
Depreciation and amortization
-13.30%1.56M
-26.85%327K
-25.82%339K
-0.67%446K
0.45%446K
0.73%1.8M
-21.58%447K
12.84%457K
9.51%449K
11.28%444K
Other non cash items
-76.22%2.5M
11.58%655K
-3.34%636K
-80.24%614K
-90.38%591K
-60.08%10.5M
-91.08%587K
-89.86%658K
-52.32%3.11M
-8.41%6.14M
Change In working capital
-363.68%-85.12M
-20.51%22.55M
-316.69%-136.41M
396.84%18.34M
110.05%10.4M
90.83%-18.36M
166.53%28.37M
209.48%62.95M
90.40%-6.18M
-189.18%-103.5M
-Change in receivables
-73.17%-101.28M
-246.78%-20.67M
-616.91%-131.4M
157.74%21.12M
148.33%29.68M
70.57%-58.48M
137.89%14.09M
143.56%25.42M
53.94%-36.58M
-158.28%-61.42M
-Change in inventory
-41.95%-15.27M
-186.40%-8.66M
-37.59%5.4M
-79.24%-26.01M
193.81%14M
82.27%-10.76M
120.96%10.02M
85.29%8.66M
17.77%-14.51M
-10,461.81%-14.92M
-Change in prepaid assets
-125.91%-8.09M
-68.69%5.07M
-145.93%-2.38M
-43.87%7.95M
-331.67%-18.73M
152.27%31.21M
-19.26%16.19M
150.80%5.19M
436.34%14.17M
-3,954.21%-4.34M
-Change in payables and accrued expense
126.65%43.61M
478.49%43.78M
-156.25%-8.56M
-34.83%21.84M
63.72%-13.45M
-45.21%19.24M
-75.95%7.57M
45.90%15.22M
48.67%33.51M
-26.38%-37.06M
-Change in other current assets
-676.03%-4.06M
84.57%-1.52M
538.83%5.35M
-538.14%-6.78M
-110.27%-1.11M
-93.97%705K
-8.50%-9.87M
120.76%837K
-114.07%-1.06M
-37.52%10.8M
-Change in other working capital
87.73%-34K
47.04%-143K
93.50%-113K
112.56%215K
-99.80%7K
-246.25%-277K
---270K
---1.74M
---1.71M
--3.44M
Cash from discontinued investing activities
Operating cash flow
151.59%45.33M
-173.22%-14.18M
218.13%108.47M
153.30%4.45M
59.84%-53.41M
85.23%-87.87M
119.78%19.36M
120.17%34.1M
94.45%-8.34M
25.13%-132.98M
Investing cash flow
Cash flow from continuing investing activities
22.33%-313K
-440.00%-108K
-148K
45.56%-49K
97.27%-8K
40.21%-403K
-600.00%-20K
0
75.81%-90K
-13.13%-293K
Net PPE purchase and sale
22.33%-313K
-440.00%-108K
---148K
45.56%-49K
97.27%-8K
40.21%-403K
-600.00%-20K
--0
75.81%-90K
-13.13%-293K
Net investment purchase and sale
----
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
22.33%-313K
-440.00%-108K
---148K
45.56%-49K
97.27%-8K
40.21%-403K
-600.00%-20K
--0
75.81%-90K
-13.13%-293K
Financing cash flow
Cash flow from continuing financing activities
-94.05%8.88M
131.48%1.26M
-68.80%793K
-84.56%6.56M
-99.75%274K
-62.17%149.24M
-2.22%-4M
-55.76%2.54M
2,623.53%42.49M
-72.33%108.21M
Net issuance payments of debt
--0
--0
--0
----
----
--365.45M
--0
--0
----
----
Net common stock issuance
--0
----
----
----
----
--0
--0
--0
---98.76M
-74.31%98.76M
Proceeds from stock option exercised by employees
-52.76%8.9M
-23.23%1.26M
-68.82%797K
27.22%6.56M
-97.03%281K
-75.44%18.83M
-93.95%1.64M
-55.60%2.56M
-80.24%5.16M
-46.51%9.48M
Net other financing activities
100.00%-11K
--0
71.43%-4K
--0
-100.01%-7K
-253.23%-235.04M
81.81%-5.64M
-27.27%-14K
-1,237.74%-328.12M
997.67%98.74M
Cash from discontinued financing activities
Financing cash flow
-94.05%8.88M
131.48%1.26M
-68.80%793K
-84.56%6.56M
-99.75%274K
-62.17%149.24M
-2.22%-4M
-55.76%2.54M
2,623.53%42.49M
-72.33%108.21M
Net cash flow
Beginning cash position
17.12%412.61M
20.68%480.6M
2.78%371.47M
10.03%359.83M
17.12%412.61M
-36.30%352.3M
-12.19%398.24M
-41.45%361.43M
-57.33%327.03M
-36.30%352.3M
Current changes in cash
-11.60%53.9M
-184.91%-13.03M
197.81%109.11M
-67.84%10.95M
-112.03%-53.14M
130.35%60.97M
115.07%15.34M
122.42%36.64M
122.86%34.06M
-111.75%-25.06M
Effect of exchange rate changes
289.68%1.25M
119.07%184K
-87.28%22K
100.29%685K
271.77%359K
-588.15%-659K
-265.24%-965K
137.77%173K
827.66%342K
-473.21%-209K
End cash Position
13.37%467.76M
13.37%467.76M
20.68%480.6M
2.78%371.47M
10.03%359.83M
17.12%412.61M
17.12%412.61M
-12.19%398.24M
-41.45%361.43M
-57.33%327.03M
Free cash flow
151.00%45.01M
-173.86%-14.28M
217.69%108.32M
152.15%4.4M
59.92%-53.42M
85.18%-88.27M
119.74%19.34M
120.16%34.1M
94.40%-8.43M
25.07%-133.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 151.59%45.33M-173.22%-14.18M218.13%108.47M153.30%4.45M59.84%-53.41M85.23%-87.87M119.78%19.36M120.17%34.1M94.45%-8.34M25.13%-132.98M
Net income from continuing operations 111.31%22.39M-62.16%-58.95M475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M
Operating gains losses --------------------1,524.17%1.95M--0--0--------
Depreciation and amortization -13.30%1.56M-26.85%327K-25.82%339K-0.67%446K0.45%446K0.73%1.8M-21.58%447K12.84%457K9.51%449K11.28%444K
Other non cash items -76.22%2.5M11.58%655K-3.34%636K-80.24%614K-90.38%591K-60.08%10.5M-91.08%587K-89.86%658K-52.32%3.11M-8.41%6.14M
Change In working capital -363.68%-85.12M-20.51%22.55M-316.69%-136.41M396.84%18.34M110.05%10.4M90.83%-18.36M166.53%28.37M209.48%62.95M90.40%-6.18M-189.18%-103.5M
-Change in receivables -73.17%-101.28M-246.78%-20.67M-616.91%-131.4M157.74%21.12M148.33%29.68M70.57%-58.48M137.89%14.09M143.56%25.42M53.94%-36.58M-158.28%-61.42M
-Change in inventory -41.95%-15.27M-186.40%-8.66M-37.59%5.4M-79.24%-26.01M193.81%14M82.27%-10.76M120.96%10.02M85.29%8.66M17.77%-14.51M-10,461.81%-14.92M
-Change in prepaid assets -125.91%-8.09M-68.69%5.07M-145.93%-2.38M-43.87%7.95M-331.67%-18.73M152.27%31.21M-19.26%16.19M150.80%5.19M436.34%14.17M-3,954.21%-4.34M
-Change in payables and accrued expense 126.65%43.61M478.49%43.78M-156.25%-8.56M-34.83%21.84M63.72%-13.45M-45.21%19.24M-75.95%7.57M45.90%15.22M48.67%33.51M-26.38%-37.06M
-Change in other current assets -676.03%-4.06M84.57%-1.52M538.83%5.35M-538.14%-6.78M-110.27%-1.11M-93.97%705K-8.50%-9.87M120.76%837K-114.07%-1.06M-37.52%10.8M
-Change in other working capital 87.73%-34K47.04%-143K93.50%-113K112.56%215K-99.80%7K-246.25%-277K---270K---1.74M---1.71M--3.44M
Cash from discontinued investing activities
Operating cash flow 151.59%45.33M-173.22%-14.18M218.13%108.47M153.30%4.45M59.84%-53.41M85.23%-87.87M119.78%19.36M120.17%34.1M94.45%-8.34M25.13%-132.98M
Investing cash flow
Cash flow from continuing investing activities 22.33%-313K-440.00%-108K-148K45.56%-49K97.27%-8K40.21%-403K-600.00%-20K075.81%-90K-13.13%-293K
Net PPE purchase and sale 22.33%-313K-440.00%-108K---148K45.56%-49K97.27%-8K40.21%-403K-600.00%-20K--075.81%-90K-13.13%-293K
Net investment purchase and sale ----------------------0----------------
Cash from discontinued investing activities
Investing cash flow 22.33%-313K-440.00%-108K---148K45.56%-49K97.27%-8K40.21%-403K-600.00%-20K--075.81%-90K-13.13%-293K
Financing cash flow
Cash flow from continuing financing activities -94.05%8.88M131.48%1.26M-68.80%793K-84.56%6.56M-99.75%274K-62.17%149.24M-2.22%-4M-55.76%2.54M2,623.53%42.49M-72.33%108.21M
Net issuance payments of debt --0--0--0----------365.45M--0--0--------
Net common stock issuance --0------------------0--0--0---98.76M-74.31%98.76M
Proceeds from stock option exercised by employees -52.76%8.9M-23.23%1.26M-68.82%797K27.22%6.56M-97.03%281K-75.44%18.83M-93.95%1.64M-55.60%2.56M-80.24%5.16M-46.51%9.48M
Net other financing activities 100.00%-11K--071.43%-4K--0-100.01%-7K-253.23%-235.04M81.81%-5.64M-27.27%-14K-1,237.74%-328.12M997.67%98.74M
Cash from discontinued financing activities
Financing cash flow -94.05%8.88M131.48%1.26M-68.80%793K-84.56%6.56M-99.75%274K-62.17%149.24M-2.22%-4M-55.76%2.54M2,623.53%42.49M-72.33%108.21M
Net cash flow
Beginning cash position 17.12%412.61M20.68%480.6M2.78%371.47M10.03%359.83M17.12%412.61M-36.30%352.3M-12.19%398.24M-41.45%361.43M-57.33%327.03M-36.30%352.3M
Current changes in cash -11.60%53.9M-184.91%-13.03M197.81%109.11M-67.84%10.95M-112.03%-53.14M130.35%60.97M115.07%15.34M122.42%36.64M122.86%34.06M-111.75%-25.06M
Effect of exchange rate changes 289.68%1.25M119.07%184K-87.28%22K100.29%685K271.77%359K-588.15%-659K-265.24%-965K137.77%173K827.66%342K-473.21%-209K
End cash Position 13.37%467.76M13.37%467.76M20.68%480.6M2.78%371.47M10.03%359.83M17.12%412.61M17.12%412.61M-12.19%398.24M-41.45%361.43M-57.33%327.03M
Free cash flow 151.00%45.01M-173.86%-14.28M217.69%108.32M152.15%4.4M59.92%-53.42M85.18%-88.27M119.74%19.34M120.16%34.1M94.40%-8.43M25.07%-133.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More